PLoS ONE · 2012 · 121 citations · 34 references
Veterinary MedicineInfectious DiseasesPreventive MedicineInfectious Disease EpidemiologyMolecular VirologyVirologyInfectious Disease PreventionInfectious Disease SurveillanceInfluenza-like Illness SurveillanceRespiratory Disease Epidemiology In ChildrenRespiratory Infectious DiseasesViral EpidemiologyPediatric Influenza EpidemiologySeasonality Of Respiratory InfectionsViral CultureViral Load AssaysViral Load AssessmentViral Shedding Assessment
BACKGROUND: Influenza viral shedding studies provide fundamental information for preventive strategies and modelling exercises. We conducted a prospective household study to investigate viral shedding in seasonal and pandemic influenza between 2007 and 2011 in Berlin and Munich, Germany. METHODS: Study physicians recruited index patients and their household members. Serial nasal specimens were obtained from all household members over at least eight days and tested quantitatively by qRT-PCR for the influenza virus (sub)type of the index patient. A subset of samples was also tested by viral culture. Symptoms were recorded daily. RESULTS: We recruited 122 index patients and 320 household contacts, of which 67 became secondary household cases. Among all 189 influenza cases, 12 were infected with seasonal/prepandemic influenza A(H1N1), 19 with A(H3N2), 60 with influenza B, and 98 with A(H1N1)pdm09. Nine (14%) of 65 non-vaccinated secondary cases were asymptomatic/subclinical (0 (0%) of 21 children, 9 (21%) of 44 adults; p = 0.03). Viral load among patients with influenza-like illness (ILI) peaked on illness days 1, 2 or 3 for all (sub)types and declined steadily until days 7-9. Clinical symptom scores roughly paralleled viral shedding dynamics. On the first day prior to symptom onset 30% (12/40) of specimens were positive. Viral load in 6 asymptomatic/subclinical patients was similar to that in ILI-patients. Duration of infectiousness as measured by viral culture lasted approximately until illness days 4-6. Viral load did not seem to be influenced by antiviral therapy, age or vaccination status. CONCLUSION: Asymptomatic/subclinical infections occur infrequently, but may be associated with substantial amounts of viral shedding. Presymptomatic shedding may arise in one third of cases, and shedding characteristics appear to be independent of (seasonal or pandemic) (sub)type, age, antiviral therapy or vaccination; however the power to find moderate differences was limited.
34
Strategies for mitigating an influenza pandemic
Neil M. Ferguson, Derek A. T. Cummings, Christophe Fraser et al. · Nature · 2006 · 2.3K citations · Full text
Public Health, Emergency Preparedness, Infectious Disease Control +12
Strategies for containing an emerging influenza pandemic in Southeast Asia
Neil M. Ferguson, Derek A. T. Cummings, Simon Cauchemez et al. · Nature · 2005 · 1.9K citations · Full text
Medicine, Infectious Disease Control, Infectious Diseases +14
Use of the Oral Neuraminidase Inhibitor Oseltamivir in Experimental Human Influenza
Frederick G. Hayden, John J. Treanor, Richard Fritz et al. · JAMA · 1999 · 558 citations